Analyst
Jefferies
Equibles does not estimate personal net worth.
Dennis Deng is recorded as Analyst at Jefferies. Dennis Deng has spoken on 2 earnings calls and 5 other investor events across 7 companies, most recently for Ooma Inc on September 29, 2026. Those appearances were for Ooma Inc (OOMA), Energy Vault Holdings, Inc. (NRGV), Tarsus Pharmaceuticals, Inc. (TARS), Mineralys Therapeutics, Inc. (MLYS), Amphastar Pharmaceuticals, Inc. (AMPH) and 2 other companies. The companies whose calls Dennis Deng spoke on are classified in the Technology, Utilities, Healthcare and Real Estate sectors.
“I'm here to talk about the UCAS side of the business. UCAS is the phone, messaging, and collaboration solution that businesses rely on every day.”
“I have the wonderful pleasure of having Tarsus Pharmaceuticals We have the CFO and CSO, Jeff Farrow, and the Chief Commercial Officer, Aziz Matawalla.”
“I have the pleasure of having CEO John Congleton and also CFO Adam Levy here with us from Mineralis Therapeutics. And I'm going to turn it over to you, Adam, to give a brief overview around what happened this morning and then the rest of the presentation.”
“I have the great pleasure of having Amphistar Pharmaceuticals here with us. We have the CFO, Bill Peters, as well as Jacob Lea-Wadadui, EVP of Corporate Administration, here with us.”
Jefferies
Analyst
Transcript header (unverified)
OOMA
Software - Application · Technology
Drug Manufacturers - Specialty & Generic · Healthcare
